Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on metal free. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115353482B enables cost reduction in API manufacturing via metal-free synthesis of high-purity trifluoromethyl selenium azaspiro intermediates with scalable process and reduced lead time.
Novel metal-free synthesis enables high-purity triazole intermediates with reliable supply chain and manufacturing cost reduction.
Metal-free synthesis of 5-trifluoromethyl triazole compounds enables scalable production with high purity and reduced manufacturing costs for pharmaceutical applications.
Metal-free synthesis enables high-purity azaspiro intermediates with scalable production and reduced lead time for pharmaceutical applications.
Patent CN115353482B introduces a metal-free synthesis method for high-purity azaspiro compounds enabling cost reduction and scalable production This innovative process eliminates heavy metal catalysts reducing purification costs and ensuring reliable supply chain continuity for pharmaceutical intermediates
Patent CN118126005B enables metal-free synthesis of high-purity dihydrobenzofuran intermediates, reducing lead time and manufacturing costs for pharmaceutical applications.
Patent CN116253692A enables metal-free triazine synthesis at room temperature, reducing manufacturing costs and ensuring supply chain continuity for pharmaceutical intermediates.
Discover how glucose-based synthesis of 3-trifluoromethyl-1,2,4-triazole eliminates anhydrous/oxygen-free requirements, cuts production costs, and ensures 99% purity for pharmaceutical intermediates.
Solve supply chain risks with metal-free, room-temperature pyrazole synthesis. NINGBO INNO PHARMCHEM scales this patent-protected method for high-purity intermediates.
New 4,5-dihydropyrazole method eliminates anhydrous conditions, cuts costs 30%, and ensures supply chain stability for pharmaceutical manufacturing.
Solve chiral drug synthesis challenges with metal-free catalysis. Achieve >99% ee, mild conditions, and scalable production for pharmaceutical intermediates. Reduce costs and supply chain risks.
Solve high-cost N-difluoromethylation challenges with this room-temperature, metal-free method. 90% yields, broad substrate tolerance, and no special equipment needed. Scale to 100 MT/yr.
Solve high-cost deuteration challenges with 98% deuterated aldehyde yield. Our CDMO expertise in metal-free catalysis ensures scalable, pure intermediates for drug development.
Solve 5-trifluoromethyl imidazole synthesis challenges with our CDMO's scalable, high-yield process. Reduce costs by 30% and ensure supply chain stability for your API development.
Discover metal-free β-iodonitroalkene synthesis with 80%+ yields. Eliminate oxidant risks & simplify GMP production for API intermediates.
Solve metal contamination risks in 2-trifluoromethyl quinoline production. Our green, catalyst-free process ensures high purity and scalable manufacturing for drug development.
Eliminate heavy metal catalysts and nitrogen protection in pyrazole synthesis. Scale to 100MT/yr with 99% purity for drug development.
Solve low yield & high cost in fexuprazan intermediate production. New route with >50% yield, 50% cost reduction. Scale to 100MT/yr.
Solve 1,2,4-triazole synthesis challenges: 97% yield, no heavy metals, no anhydrous conditions. Reduce R&D costs and supply chain risks for API manufacturing.
Discover how metal-free diselenomaleimide synthesis at room temperature reduces production costs and supply chain risks for pharmaceutical intermediates. High-yield, scalable solution for R&D and procurement teams.